Consequently, pyroptosis-released factors activate caspase-1 for gasdermin D (GSDMD) cleavage in macrophages to stimulate macrophages to produce proinflammatory cytokines, which may trigger CRS in CAR T-cell-treated patients (Liu et al., 2020b). The gene discussed is GSDMD; the disease is congenital rubella syndrome.